381 related articles for article (PubMed ID: 32943233)
1. Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.
Rambaldi A; Gritti G; Micò MC; Frigeni M; Borleri G; Salvi A; Landi F; Pavoni C; Sonzogni A; Gianatti A; Binda F; Fagiuoli S; Di Marco F; Lorini L; Remuzzi G; Whitaker S; Demopulos G
Immunobiology; 2020 Nov; 225(6):152001. PubMed ID: 32943233
[TBL] [Abstract][Full Text] [Related]
2. Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J; Chonat S; Williams KM
Transplant Cell Ther; 2024 Mar; 30(3):336.e1-336.e8. PubMed ID: 38145741
[TBL] [Abstract][Full Text] [Related]
3. MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.
Elhadad S; Chapin J; Copertino D; Van Besien K; Ahamed J; Laurence J
Clin Exp Immunol; 2021 Jan; 203(1):96-104. PubMed ID: 32681658
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders.
Dudler T; Yaseen S; Cummings WJ
Front Immunol; 2023; 14():1297352. PubMed ID: 38022610
[TBL] [Abstract][Full Text] [Related]
5. Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.
Khaled SK; Claes K; Goh YT; Kwong YL; Leung N; Mendrek W; Nakamura R; Sathar J; Ng E; Nangia N; Whitaker S; Rambaldi A;
J Clin Oncol; 2022 Aug; 40(22):2447-2457. PubMed ID: 35439028
[TBL] [Abstract][Full Text] [Related]
6. MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence.
Elhadad S; Redmond D; Huang J; Tan A; Laurence J
Clin Exp Immunol; 2023 Jul; 213(2):252-264. PubMed ID: 37191586
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the interaction between complement lectin pathway protease MASP-2 and SARS-CoV-2 nucleoprotein.
Bally I; Drumont G; Rossi V; Guseva S; Botova M; Reiser JB; Thépaut M; Dergan Dylon S; Dumestre-Pérard C; Gaboriaud C; Fieschi F; Blackledge M; Poignard P; Thielens NM
Front Immunol; 2024; 15():1419165. PubMed ID: 38911852
[TBL] [Abstract][Full Text] [Related]
8. Narsoplimab for severe transplant-associated thrombotic microangiopathy.
Pandrowala A; Ganatra P; Krishnan VP; Sharma AN; Chavan S; Bodhanwala M; Agarwal B; Hiwarkar P
Thromb J; 2023 Mar; 21(1):26. PubMed ID: 36915123
[TBL] [Abstract][Full Text] [Related]
9. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
Kozarcanin H; Lood C; Munthe-Fog L; Sandholm K; Hamad OA; Bengtsson AA; Skjoedt MO; Huber-Lang M; Garred P; Ekdahl KN; Nilsson B
J Thromb Haemost; 2016 Mar; 14(3):531-45. PubMed ID: 26614707
[TBL] [Abstract][Full Text] [Related]
10. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins.
Ali YM; Ferrari M; Lynch NJ; Yaseen S; Dudler T; Gragerov S; Demopulos G; Heeney JL; Schwaeble WJ
Front Immunol; 2021; 12():714511. PubMed ID: 34290717
[TBL] [Abstract][Full Text] [Related]
11. Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation.
Gao T; Zhu L; Liu H; Zhang X; Wang T; Fu Y; Li H; Dong Q; Hu Y; Zhang Z; Jin J; Liu Z; Yang W; Liu Y; Jin Y; Li K; Xiao Y; Liu J; Zhao H; Liu Y; Li P; Song J; Zhang L; Gao Y; Kang S; Chen S; Ma Q; Bian X; Chen W; Liu X; Mao Q; Cao C
Signal Transduct Target Ther; 2022 Sep; 7(1):318. PubMed ID: 36100602
[TBL] [Abstract][Full Text] [Related]
12. Serum MASP-1 in complex with MBL activates endothelial cells.
Megyeri M; Jani PK; Kajdácsi E; Dobó J; Schwaner E; Major B; Rigó J; Závodszky P; Thiel S; Cervenak L; Gál P
Mol Immunol; 2014 May; 59(1):39-45. PubMed ID: 24472859
[TBL] [Abstract][Full Text] [Related]
13. Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components.
Thiel S; Jensen L; Degn SE; Nielsen HJ; Gál P; Dobó J; Jensenius JC
Clin Exp Immunol; 2012 Jul; 169(1):38-48. PubMed ID: 22670777
[TBL] [Abstract][Full Text] [Related]
14. Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy.
Lafayette RA; Rovin BH; Reich HN; Tumlin JA; Floege J; Barratt J
Kidney Int Rep; 2020 Nov; 5(11):2032-2041. PubMed ID: 33163724
[TBL] [Abstract][Full Text] [Related]
15. The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System.
Świerzko AS; Cedzyński M
Front Immunol; 2020; 11():585243. PubMed ID: 33193407
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the Lectin Pathway of Complement Activation Reduces Acute Respiratory Distress Syndrome Severity in a Mouse Model of SARS-CoV-2 Infection.
Ali YM; Carnell GW; Fumagalli S; Mercurio D; Seminara S; Lynch NJ; Khatri P; Arachchilage CH; Mascheroni L; Kaminski C; George CL; Stewart H; Yabuki M; Demopulos G; Heeney JL; Schwaeble W
J Infect Dis; 2024 Mar; 229(3):680-690. PubMed ID: 37878754
[TBL] [Abstract][Full Text] [Related]
17. TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2.
Keizer MP; Pouw RB; Kamp AM; Patiwael S; Marsman G; Hart MH; Zeerleder S; Kuijpers TW; Wouters D
Eur J Immunol; 2015 Feb; 45(2):544-50. PubMed ID: 25359215
[TBL] [Abstract][Full Text] [Related]
18. The Structural Basis for Complement Inhibition by Gigastasin, a Protease Inhibitor from the Giant Amazon Leech.
Pang SS; Wijeyewickrema LC; Hor L; Tan S; Lameignere E; Conway EM; Blom AM; Mohlin FC; Liu X; Payne RJ; Whisstock JC; Pike RN
J Immunol; 2017 Dec; 199(11):3883-3891. PubMed ID: 29061764
[TBL] [Abstract][Full Text] [Related]
19. Monospecific inhibitors show that both mannan-binding lectin-associated serine protease-1 (MASP-1) and -2 Are essential for lectin pathway activation and reveal structural plasticity of MASP-2.
Héja D; Harmat V; Fodor K; Wilmanns M; Dobó J; Kékesi KA; Závodszky P; Gál P; Pál G
J Biol Chem; 2012 Jun; 287(24):20290-300. PubMed ID: 22511776
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience.
Castelli M; Micò MC; Grassi A; Algarotti A; Lussana F; Finazzi MC; Rambaldi B; Pavoni C; Rizzuto G; Tebaldi P; Vendemini F; Verna M; Bonanomi S; Biondi A; Balduzzi A; Rambaldi A; Gotti G
Bone Marrow Transplant; 2024 May; ():. PubMed ID: 38773280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
